chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Temperature of 104 F after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Temperature of 104 F after 1st dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040b21a) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient was hospitalised for a week.) in January 2021.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Temperature of 104 F after 1st dose). At the time of the report, PYREXIA (Temperature of 104 F after 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: invalid dosing interval day 43; Vaccination Site Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination Site Pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dosing interval day 43) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included Le Fort osteotomy (Underwent Maxilla Lefort surgery from tripping over dog at her house.) on 30-Mar-2021.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination Site Pain). On 15-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dosing interval day 43). At the time of the report, VACCINATION SITE PAIN (Vaccination Site Pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (invalid dosing interval day 43) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dehydration, Fatigue, Feeling hot, Pain in extremity
Clinical narrative: sluggish; very dehydrated; little hot; tired; sore arm which was for about 3 days; woke up with coughing; itchy throat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm which was for about 3 days), COUGH (woke up with coughing), THROAT IRRITATION (itchy throat), SLUGGISHNESS (sluggish) and DEHYDRATION (very dehydrated) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced COUGH (woke up with coughing) and THROAT IRRITATION (itchy throat). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm which was for about 3 days), SLUGGISHNESS (sluggish), DEHYDRATION (very dehydrated), FEELING HOT (little hot) and FATIGUE (tired). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm which was for about 3 days) was resolving and COUGH (woke up with coughing), THROAT IRRITATION (itchy throat), SLUGGISHNESS (sluggish), DEHYDRATION (very dehydrated), FEELING HOT (little hot) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness, Throat irritation
Clinical narrative: sluggish; very dehydrated; little hot; tired; sore arm which was for about 3 days; woke up with coughing; itchy throat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm which was for about 3 days), COUGH (woke up with coughing), THROAT IRRITATION (itchy throat), SLUGGISHNESS (sluggish) and DEHYDRATION (very dehydrated) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced COUGH (woke up with coughing) and THROAT IRRITATION (itchy throat). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm which was for about 3 days), SLUGGISHNESS (sluggish), DEHYDRATION (very dehydrated), FEELING HOT (little hot) and FATIGUE (tired). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Allergy, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm which was for about 3 days) was resolving and COUGH (woke up with coughing), THROAT IRRITATION (itchy throat), SLUGGISHNESS (sluggish), DEHYDRATION (very dehydrated), FEELING HOT (little hot) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID ) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced COVID-19 (COVID ). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID ) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive. On 10-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive. On 13-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: Got Covid after first dose; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Got Covid after first dose) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced SUSPECTED COVID-19 (Got Covid after first dose). At the time of the report, SUSPECTED COVID-19 (Got Covid after first dose) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Patient needed to push the second dose. Patient finishes quarantining on 17-Apr-2021, the date of her second dose.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Magnetic resonance imaging, Neck pain, Pain in extremity
Clinical narrative: Dizziness; Pain in neck; Pain in legs; Pain in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), NECK PAIN (Pain in neck), PAIN IN EXTREMITY (Pain in legs) and ARTHRALGIA (Pain in shoulder) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00121A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (Dizziness), NECK PAIN (Pain in neck), PAIN IN EXTREMITY (Pain in legs) and ARTHRALGIA (Pain in shoulder). At the time of the report, DIZZINESS (Dizziness), NECK PAIN (Pain in neck), PAIN IN EXTREMITY (Pain in legs) and ARTHRALGIA (Pain in shoulder) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: unknown (Inconclusive) unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is skeptical about second dose because of the events. She stated she normally walks 4 miles a day. Patient wanted to knowthe effectiveness after one dose. No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound Doppler, Vaccination site pain
Clinical narrative: Vaccination site pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 046321A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 4 UNK. At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Ultrasound Doppler: all clear (normal) was all clear.         No concomitant medications was reported by the reporter No treatment medications was  provided by the reporter.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced NAUSEA (nausea). At the time of the report, NAUSEA (nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.  The patient Vaccination card  was unavailable
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Got second dose after 55 days after first one; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got second dose after 55 days after first one) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported).   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got second dose after 55 days after first one). On 14-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got second dose after 55 days after first one) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received the Moderna vaccine for her first dose. On 15April2021, she received the Pfizer vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received the Moderna vaccine for her first dose. On 15April2021, she received the Pfizer vaccine) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received the Moderna vaccine for her first dose. On 15April2021, she received the Pfizer vaccine). On 15-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (Patient received the Moderna vaccine for her first dose. On 15April2021, she received the Pfizer vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: experiencing short pain in elbow (in the same arm got his shot),Feels like some one hit him; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (experiencing short pain in elbow (in the same arm got his shot),Feels like some one hit him) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced ARTHRALGIA (experiencing short pain in elbow (in the same arm got his shot),Feels like some one hit him). At the time of the report, ARTHRALGIA (experiencing short pain in elbow (in the same arm got his shot),Feels like some one hit him) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: red area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red area at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 36821A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area at the injection site). On 18-Mar-2021, VACCINATION SITE ERYTHEMA (red area at the injection site) had resolved. Not Provided          Concomitant medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-077804 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077804:CROSSLINKED WITH DOSE 2
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Vaccination site haemorrhage
Clinical narrative: bled quite a bit (trickle of blood); Potentially did not receive full dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (bled quite a bit (trickle of blood)) and INCORRECT DOSE ADMINISTERED (Potentially did not receive full dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (bled quite a bit (trickle of blood)) and INCORRECT DOSE ADMINISTERED (Potentially did not receive full dose). On 14-Apr-2021, INCORRECT DOSE ADMINISTERED (Potentially did not receive full dose) had resolved. At the time of the report, VACCINATION SITE HAEMORRHAGE (bled quite a bit (trickle of blood)) outcome was unknown.            Concomitant medications were not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Pain
Clinical narrative: redness; below the injection site left is red in color; (below the injection site) very warm; headaches; chills; body aches; fatigued; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02B21A). The report describes a case of HEADACHE (headaches), CHILLS (chills), PAIN (body aches), FATIGUE (fatigued) and ERYTHEMA (redness). The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical History).  On 12-Apr-2021, the patient experienced HEADACHE (headaches), CHILLS (chills), PAIN (body aches) and FATIGUE (fatigued). On 15-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (below the injection site left is red in color) and VACCINATION SITE WARMTH ((below the injection site) very warm). On an unknown date, the patient experienced ERYTHEMA (redness). At the time of the report, HEADACHE (headaches), CHILLS (chills), PAIN (body aches), FATIGUE (fatigued), ERYTHEMA (redness), VACCINATION SITE ERYTHEMA (below the injection site left is red in color) and VACCINATION SITE WARMTH ((below the injection site) very warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment information not provided   This case was linked to MOD-2021-077774 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-077774:First dose US-MODERNATX, INC.-MOD-2021-077774:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: redness; below the injection site left is red in color; (below the injection site) very warm; headaches; chills; body aches; fatigued; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02B21A). The report describes a case of HEADACHE (headaches), CHILLS (chills), PAIN (body aches), FATIGUE (fatigued) and ERYTHEMA (redness). The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical History).  On 12-Apr-2021, the patient experienced HEADACHE (headaches), CHILLS (chills), PAIN (body aches) and FATIGUE (fatigued). On 15-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (below the injection site left is red in color) and VACCINATION SITE WARMTH ((below the injection site) very warm). On an unknown date, the patient experienced ERYTHEMA (redness). At the time of the report, HEADACHE (headaches), CHILLS (chills), PAIN (body aches), FATIGUE (fatigued), ERYTHEMA (redness), VACCINATION SITE ERYTHEMA (below the injection site left is red in color) and VACCINATION SITE WARMTH ((below the injection site) very warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment information not provided   This case was linked to MOD-2021-077774 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-077774:First dose US-MODERNATX, INC.-MOD-2021-077774:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Muscle spasms, Myalgia, Pain
Clinical narrative: Bodyache; Aches and cramps; chills; headache; Sore muscles; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Bodyache), MUSCLE SPASMS (Aches and cramps), CHILLS (chills), HEADACHE (headache) and MYALGIA (Sore muscles) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PAIN (Bodyache), MUSCLE SPASMS (Aches and cramps), CHILLS (chills), HEADACHE (headache) and MYALGIA (Sore muscles). At the time of the report, PAIN (Bodyache), MUSCLE SPASMS (Aches and cramps), CHILLS (chills), HEADACHE (headache) and MYALGIA (Sore muscles) outcome was unknown. Not Provided          No concomitant medications were reported. No corrective treatment was reported.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (headache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Neurologic disorder NOS.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided          No concomitant medications were reported. The patient's  doctor requested that he wait until 2 weeks after second dose of vaccination to start any medication to prevent any drug interaction. No corrective treatment was reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Pain, Pyrexia
Clinical narrative: Soreness of her body; Feels really weak; Tiredness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness of her body), ASTHENIA (Feels really weak), FATIGUE (Tiredness) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021GZ1A and OA8A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced PAIN (Soreness of her body), ASTHENIA (Feels really weak) and FATIGUE (Tiredness). 13-Apr-2021, the patient experienced PYREXIA (Fever). At the time of the report, PAIN (Soreness of her body), ASTHENIA (Feels really weak), FATIGUE (Tiredness) and PYREXIA (Fever) outcome was unknown.            Concomitant product information includes Blood Pressure medicines. Treatment information was not provided. Action taken with mRNA-1273v in response to the events was not applicable.   This case was linked to MOD21-076085 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Additional Information received Patient demographics were added.Dose 1 and 2 details were added.Events Fever,Tiredness,Soreness of body,Feels really weak were added; Sender's Comments:  MOD21-076085:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Oropharyngeal pain, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: injeciotn site is warm; injection site is swollen; injection site is itchy; injection site is red; Chills; Sore Throat; Aching Bones; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), BONE PAIN (Aching Bones), VACCINATION SITE WARMTH (injeciotn site is warm), CHILLS (Chills) and VACCINATION SITE SWELLING (injection site is swollen) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 12-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat), BONE PAIN (Aching Bones) and CHILLS (Chills). On 15-Apr-2021, the patient experienced VACCINATION SITE WARMTH (injeciotn site is warm), VACCINATION SITE SWELLING (injection site is swollen), VACCINATION SITE PRURITUS (injection site is itchy) and VACCINATION SITE ERYTHEMA (injection site is red). On 15-Apr-2021, OROPHARYNGEAL PAIN (Sore Throat), BONE PAIN (Aching Bones) and CHILLS (Chills) had resolved. On 18-Apr-2021, VACCINATION SITE ERYTHEMA (injection site is red) had resolved. At the time of the report, VACCINATION SITE WARMTH (injeciotn site is warm), VACCINATION SITE SWELLING (injection site is swollen) and VACCINATION SITE PRURITUS (injection site is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were given by the reporter. No treatment medication were given by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-077797 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077797:CROSSLINKED WITH DOSE 1
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: injeciotn site is warm; injection site is swollen; injection site is itchy; injection site is red; Chills; Sore Throat; Aching Bones; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), BONE PAIN (Aching Bones), VACCINATION SITE WARMTH (injeciotn site is warm), CHILLS (Chills) and VACCINATION SITE SWELLING (injection site is swollen) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 12-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat), BONE PAIN (Aching Bones) and CHILLS (Chills). On 15-Apr-2021, the patient experienced VACCINATION SITE WARMTH (injeciotn site is warm), VACCINATION SITE SWELLING (injection site is swollen), VACCINATION SITE PRURITUS (injection site is itchy) and VACCINATION SITE ERYTHEMA (injection site is red). On 15-Apr-2021, OROPHARYNGEAL PAIN (Sore Throat), BONE PAIN (Aching Bones) and CHILLS (Chills) had resolved. On 18-Apr-2021, VACCINATION SITE ERYTHEMA (injection site is red) had resolved. At the time of the report, VACCINATION SITE WARMTH (injeciotn site is warm), VACCINATION SITE SWELLING (injection site is swollen) and VACCINATION SITE PRURITUS (injection site is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were given by the reporter. No treatment medication were given by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-077797 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077797:CROSSLINKED WITH DOSE 1
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Feeling abnormal, Headache
Clinical narrative: weak; sore/Still hurting; triggered her menstrual cycle even though she is postmenopausal; feels awful; nauseas; Injection site is itching; Injection site is red; hurts like she was punched; chills; headache/terrible headache; very tired; swollen like a baseball; bottom of feet hurt; swollen; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN (sore/Still hurting) and PAIN IN EXTREMITY (bottom of feet hurt) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (bottom of feet hurt), SWELLING (swollen like a baseball), FATIGUE (very tired), CHILLS (chills) and HEADACHE (headache/terrible headache). On 15-Apr-2021, the patient experienced ASTHENIA (weak), PAIN (sore/Still hurting), MENSTRUAL DISORDER (triggered her menstrual cycle even though she is postmenopausal), FEELING ABNORMAL (feels awful), NAUSEA (nauseas), VACCINATION SITE PRURITUS (Injection site is itching), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE DISCOMFORT (hurts like she was punched). At the time of the report, ASTHENIA (weak), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (bottom of feet hurt), MENSTRUAL DISORDER (triggered her menstrual cycle even though she is postmenopausal), FEELING ABNORMAL (feels awful), SWELLING (swollen like a baseball), NAUSEA (nauseas), FATIGUE (very tired), VACCINATION SITE PRURITUS (Injection site is itching), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE DISCOMFORT (hurts like she was punched), CHILLS (chills) and HEADACHE (headache/terrible headache) outcome was unknown and PAIN (sore/Still hurting) had not resolved.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-077767 (Patient Link).
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Nausea, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: weak; sore/Still hurting; triggered her menstrual cycle even though she is postmenopausal; feels awful; nauseas; Injection site is itching; Injection site is red; hurts like she was punched; chills; headache/terrible headache; very tired; swollen like a baseball; bottom of feet hurt; swollen; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN (sore/Still hurting) and PAIN IN EXTREMITY (bottom of feet hurt) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (bottom of feet hurt), SWELLING (swollen like a baseball), FATIGUE (very tired), CHILLS (chills) and HEADACHE (headache/terrible headache). On 15-Apr-2021, the patient experienced ASTHENIA (weak), PAIN (sore/Still hurting), MENSTRUAL DISORDER (triggered her menstrual cycle even though she is postmenopausal), FEELING ABNORMAL (feels awful), NAUSEA (nauseas), VACCINATION SITE PRURITUS (Injection site is itching), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE DISCOMFORT (hurts like she was punched). At the time of the report, ASTHENIA (weak), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (bottom of feet hurt), MENSTRUAL DISORDER (triggered her menstrual cycle even though she is postmenopausal), FEELING ABNORMAL (feels awful), SWELLING (swollen like a baseball), NAUSEA (nauseas), FATIGUE (very tired), VACCINATION SITE PRURITUS (Injection site is itching), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE DISCOMFORT (hurts like she was punched), CHILLS (chills) and HEADACHE (headache/terrible headache) outcome was unknown and PAIN (sore/Still hurting) had not resolved.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-077767 (Patient Link).
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site discomfort, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: weak; sore/Still hurting; triggered her menstrual cycle even though she is postmenopausal; feels awful; nauseas; Injection site is itching; Injection site is red; hurts like she was punched; chills; headache/terrible headache; very tired; swollen like a baseball; bottom of feet hurt; swollen; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN (sore/Still hurting) and PAIN IN EXTREMITY (bottom of feet hurt) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (bottom of feet hurt), SWELLING (swollen like a baseball), FATIGUE (very tired), CHILLS (chills) and HEADACHE (headache/terrible headache). On 15-Apr-2021, the patient experienced ASTHENIA (weak), PAIN (sore/Still hurting), MENSTRUAL DISORDER (triggered her menstrual cycle even though she is postmenopausal), FEELING ABNORMAL (feels awful), NAUSEA (nauseas), VACCINATION SITE PRURITUS (Injection site is itching), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE DISCOMFORT (hurts like she was punched). At the time of the report, ASTHENIA (weak), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (bottom of feet hurt), MENSTRUAL DISORDER (triggered her menstrual cycle even though she is postmenopausal), FEELING ABNORMAL (feels awful), SWELLING (swollen like a baseball), NAUSEA (nauseas), FATIGUE (very tired), VACCINATION SITE PRURITUS (Injection site is itching), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE DISCOMFORT (hurts like she was punched), CHILLS (chills) and HEADACHE (headache/terrible headache) outcome was unknown and PAIN (sore/Still hurting) had not resolved.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-077767 (Patient Link).
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Cough, Illness, Influenza, Oropharyngeal pain
Clinical narrative: Sick; Fever; influenza A; Sore throat; Could not talk; Dry cough; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021 and was forwarded to Moderna on 15-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (influenza A), COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat), APHASIA (Could not talk) and ILLNESS (Sick) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced COUGH (Dry cough). On 09-Apr-2021, the patient experienced INFLUENZA (influenza A), OROPHARYNGEAL PAIN (Sore throat), APHASIA (Could not talk) and PYREXIA (Fever). On an unknown date, the patient experienced ILLNESS (Sick). On 14-Apr-2021, INFLUENZA (influenza A), COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat) and PYREXIA (Fever) had resolved. At the time of the report, APHASIA (Could not talk) had resolved and ILLNESS (Sick) outcome was unknown.            No concomitants medications was reported.  No treatments medications was reported. Patient stated that he had his second shot of Moderna vaccine and did not have any adverse reaction.   This case was linked to US-MODERNATX, INC.-MOD-2021-077839 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up information received on 04 Aug 2021 contains information for 2nd dose.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077839:wife's case crosslinked
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sick; Fever; influenza A; Sore throat; Could not talk; Dry cough; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021 and was forwarded to Moderna on 15-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (influenza A), COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat), APHASIA (Could not talk) and ILLNESS (Sick) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced COUGH (Dry cough). On 09-Apr-2021, the patient experienced INFLUENZA (influenza A), OROPHARYNGEAL PAIN (Sore throat), APHASIA (Could not talk) and PYREXIA (Fever). On an unknown date, the patient experienced ILLNESS (Sick). On 14-Apr-2021, INFLUENZA (influenza A), COUGH (Dry cough), OROPHARYNGEAL PAIN (Sore throat) and PYREXIA (Fever) had resolved. At the time of the report, APHASIA (Could not talk) had resolved and ILLNESS (Sick) outcome was unknown.            No concomitants medications was reported.  No treatments medications was reported. Patient stated that he had his second shot of Moderna vaccine and did not have any adverse reaction.   This case was linked to US-MODERNATX, INC.-MOD-2021-077839 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up information received on 04 Aug 2021 contains information for 2nd dose.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077839:wife's case crosslinked
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chills, Feeling cold, Headache
Clinical narrative: Felt like she's experiencing COVID-19 again.; Felt weak; still felt freezing; could not stop shaking despite wrapping herself wit a lot of blankets; chills; bad Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (bad Headache), ASTHENIA (Felt weak), COVID-19 (Felt like she's experiencing COVID-19 again.) and TREMOR (could not stop shaking despite wrapping herself wit a lot of blankets) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (bad Headache) and TREMOR (could not stop shaking despite wrapping herself wit a lot of blankets). On 15-Apr-2021, the patient experienced ASTHENIA (Felt weak) and FEELING COLD (still felt freezing). On an unknown date, the patient experienced COVID-19 (Felt like she's experiencing COVID-19 again.). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CHILLS (chills), HEADACHE (bad Headache), ASTHENIA (Felt weak), COVID-19 (Felt like she's experiencing COVID-19 again.), TREMOR (could not stop shaking despite wrapping herself wit a lot of blankets) and FEELING COLD (still felt freezing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Felt like she's experiencing COVID-19 again.; Felt weak; still felt freezing; could not stop shaking despite wrapping herself wit a lot of blankets; chills; bad Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (bad Headache), ASTHENIA (Felt weak), COVID-19 (Felt like she's experiencing COVID-19 again.) and TREMOR (could not stop shaking despite wrapping herself wit a lot of blankets) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (bad Headache) and TREMOR (could not stop shaking despite wrapping herself wit a lot of blankets). On 15-Apr-2021, the patient experienced ASTHENIA (Felt weak) and FEELING COLD (still felt freezing). On an unknown date, the patient experienced COVID-19 (Felt like she's experiencing COVID-19 again.). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, CHILLS (chills), HEADACHE (bad Headache), ASTHENIA (Felt weak), COVID-19 (Felt like she's experiencing COVID-19 again.), TREMOR (could not stop shaking despite wrapping herself wit a lot of blankets) and FEELING COLD (still felt freezing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of nausea, headache and myalgia (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 9, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced nausea, headache and myalgia (sore arm). At the time of the report, nausea, headache and myalgia (sore arm): resolving. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Patient stated on Apr 15, 2021 she is feeling better; she can eat now.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID-19 virus test positive; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient states he took Tylenol for treatment of event.   This case was linked to MOD21-076049 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded.; Sender's Comments:  MOD21-076049:Follow Up received
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: pain in right side of hip and knee; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in right side of hip and knee) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced ARTHRALGIA (pain in right side of hip and knee). At the time of the report, ARTHRALGIA (pain in right side of hip and knee) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.